<?xml 
version="1.0" encoding="utf-8"?>
<rss version="2.0" 
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
>

<channel xml:lang="en">

	<title>bilaterals.org</title>
	<link>http://www.bilaterals.org/</link>
	
	<description>
			
	</description>

	<language>en</language>
	<generator>SPIP - www.spip.net</generator>
	




<item xml:lang="en">
		<title>A Kiwi-sized &quot;Spanner in the works&quot; of the TPP?</title>
		<link>http://www.bilaterals.org/spip.php?article23336</link>
		<guid isPermaLink="true">http://www.bilaterals.org/spip.php?article23336</guid>
		<dc:date>2013-06-17 05:19:28</dc:date>
		<dc:format>text/html</dc:format>
		<dc:language>en</dc:language>
		[<dc:creator></dc:creator>]


		<dc:subject>New Zealand</dc:subject>
		<dc:subject>Australia</dc:subject>
		<dc:subject>IPR</dc:subject>
		<dc:subject>medicines</dc:subject>

		<description>&lt;p&gt;Are the PBS and Pharmac under threat from the TPP? Certainly, the respective governments of both Australia and New Zealand think not. So why then the paranoia? Quite simply, we need the US more than they need us. In order to secure the TPP (and with it, for example, access to the lucrative US dairy market), both Australia and New Zealand will likely need to yield in several key areas.&lt;/p&gt;



		</description>





	</item>
<item xml:lang="en">
		<title>Live from the TPP: IP chapter shows no sign of resolution, end of negotiation in 2013 highly unlikely</title>
		<link>http://www.bilaterals.org/spip.php?article23194</link>
		<guid isPermaLink="true">http://www.bilaterals.org/spip.php?article23194</guid>
		<dc:date>2013-05-21 01:31:17</dc:date>
		<dc:format>text/html</dc:format>
		<dc:language>en</dc:language>
		[<dc:creator></dc:creator>]


		<dc:subject>IPR</dc:subject>
		<dc:subject>TPP</dc:subject>
		<dc:subject>medicines</dc:subject>

		<description>&lt;p&gt;There is a strong sense in the halls of the current TPP negotiation that the end is not in sight. And one of the primary reasons s a lack of consensus on intellectual property and pharmaceuticals issues, reports Infojustice from Lima.&lt;/p&gt;



		</description>





	</item>
<item xml:lang="en">
		<title>Investors' IP rights unbound: The danger of investment clauses to access to medicines</title>
		<link>http://www.bilaterals.org/spip.php?article23080</link>
		<guid isPermaLink="true">http://www.bilaterals.org/spip.php?article23080</guid>
		<dc:date>2013-04-25 11:41:00</dc:date>
		<dc:format>text/html</dc:format>
		<dc:language>en</dc:language>
		[<dc:creator></dc:creator>]


		<dc:subject>IPR</dc:subject>
		<dc:subject>investment</dc:subject>
		<dc:subject>medicines</dc:subject>

		<description>&lt;p&gt;Although access to medicines activists have been wise to focus our attention intently on convincing low- and middle-income countries to adopt and use all possible TRIPS-compliant flexibilities and to oppose the TRIPS-plus IP chapters in free trade agreements, we have neglected to interrogate another chapter in free trade agreements and bilateral investment treaties that perhaps pose an even greater threat to our collective access to medicines &#8211; investment chapters.&lt;/p&gt;



		</description>





	</item>
<item xml:lang="en">
		<title>India-EU FTA won't hit generic drugs industry: EU envoy</title>
		<link>http://www.bilaterals.org/spip.php?article23011</link>
		<guid isPermaLink="true">http://www.bilaterals.org/spip.php?article23011</guid>
		<dc:date>2013-04-13 21:22:11</dc:date>
		<dc:format>text/html</dc:format>
		<dc:language>en</dc:language>
		[<dc:creator></dc:creator>]


		<dc:subject>EU</dc:subject>
		<dc:subject>India</dc:subject>
		<dc:subject>medicines</dc:subject>
		<dc:subject>IPR</dc:subject>

		<description>&lt;p&gt;The much-hyped bilateral trade and investment agreement (BTIA) between India and the European Union (EU) would not impact the Indian generic drugs industry or lead to a change in the country's patent law, Jo&#227;o Cravinho, EU ambassador to India, said on Friday.&lt;/p&gt;



		</description>





	</item>
<item xml:lang="en">
		<title>India-EU FTA will imperil lives, local industry, say activists</title>
		<link>http://www.bilaterals.org/spip.php?article22997</link>
		<guid isPermaLink="true">http://www.bilaterals.org/spip.php?article22997</guid>
		<dc:date>2013-04-11 04:47:28</dc:date>
		<dc:format>text/html</dc:format>
		<dc:language>en</dc:language>
		[<dc:creator></dc:creator>]


		<dc:subject>India</dc:subject>
		<dc:subject>EU</dc:subject>
		<dc:subject>medicines</dc:subject>

		<description>&lt;p&gt;A large number of people living with HIV, cancer patients and health activists took to the streets of Delhi today asking government of India not to sign a Free Trade Agreement (FTA) with the European Union (EU) as it would be detrimental to the interests of tens of thousands of people like them in the country.&lt;/p&gt;



		</description>





	</item>
<item xml:lang="en">
		<title>Cambodian people's statement on the EU-India free trade agreement on generic drugs</title>
		<link>http://www.bilaterals.org/spip.php?article22986</link>
		<guid isPermaLink="true">http://www.bilaterals.org/spip.php?article22986</guid>
		<dc:date>2013-04-10 06:05:01</dc:date>
		<dc:format>text/html</dc:format>
		<dc:language>en</dc:language>
		[<dc:creator></dc:creator>]


		<dc:subject>actions | resistance</dc:subject>
		<dc:subject>Cambodia</dc:subject>
		<dc:subject>medicines</dc:subject>
		<dc:subject>India</dc:subject>
		<dc:subject>EU</dc:subject>

		<description>&lt;p&gt;We, Cambodian garment workers, sex workers, entertainment workers, people living with HIV, LGBTs, university students, feminists and human right activists from different networks and organisations came together to express our concern about the threat posed by the forthcoming EU-India free trade agreement to the lives of millions of people in Cambodia and many other developing countries across the world.&lt;/p&gt;



		</description>





	</item>
<item xml:lang="en">
		<title>Join the rally to oppose EU-India FTA!</title>
		<link>http://www.bilaterals.org/spip.php?article22979</link>
		<guid isPermaLink="true">http://www.bilaterals.org/spip.php?article22979</guid>
		<dc:date>2013-04-09 05:55:47</dc:date>
		<dc:format>text/html</dc:format>
		<dc:language>en</dc:language>
		[<dc:creator></dc:creator>]


		<dc:subject>actions | resistance</dc:subject>
		<dc:subject>medicines</dc:subject>
		<dc:subject>IPR</dc:subject>
		<dc:subject>India</dc:subject>
		<dc:subject>EU</dc:subject>

		<description>&lt;p&gt;Around 2000 people including people living with HIV (PLHIV), patient groups and public health activists will take to the streets and rally from Barakhamba road to Jantar Mantar at 11.00 am on 10 April 2013 to voice concerns and protest against harmful provisions being pushed by the EU-India FTA negotiations&lt;/p&gt;



		</description>





	</item>
<item xml:lang="en">
		<title>Manmohan Singh must learn from the Novartis judgement</title>
		<link>http://www.bilaterals.org/spip.php?article22949</link>
		<guid isPermaLink="true">http://www.bilaterals.org/spip.php?article22949</guid>
		<dc:date>2013-04-02 04:26:59</dc:date>
		<dc:format>text/html</dc:format>
		<dc:language>en</dc:language>
		[<dc:creator></dc:creator>]


		<dc:subject>IPR</dc:subject>
		<dc:subject>India</dc:subject>
		<dc:subject>EU</dc:subject>
		<dc:subject>medicines</dc:subject>

		<description>&lt;p&gt;Will Manmohan Singh understand the clear purpose behind the national sentiment around the Supreme Court judgment on Novartis' cancer drug Glivec? If he does, he should take a relook at the India-EU Free Trade Agreement that is cooking in his back-room.&lt;/p&gt;



		</description>





	</item>
<item xml:lang="en">
		<title>European Union sets tough conditions under FTA</title>
		<link>http://www.bilaterals.org/spip.php?article22948</link>
		<guid isPermaLink="true">http://www.bilaterals.org/spip.php?article22948</guid>
		<dc:date>2013-04-01 15:45:39</dc:date>
		<dc:format>text/html</dc:format>
		<dc:language>en</dc:language>
		[<dc:creator></dc:creator>]


		<dc:subject>India</dc:subject>
		<dc:subject>EU</dc:subject>
		<dc:subject>IPR</dc:subject>
		<dc:subject>medicines</dc:subject>

		<description>&lt;p&gt;The gains accruing to the Indian generic drugs industry as a result of the Supreme Court judgement on the Novartis case may be lost if India accepts demands by the European Union (EU) under the proposed free trade agreement (FTA) between the two sides.&lt;/p&gt;



		</description>





	</item>
<item xml:lang="en">
		<title>Indian pharma sector fears India-European Union FTA could imperil local industry</title>
		<link>http://www.bilaterals.org/spip.php?article22926</link>
		<guid isPermaLink="true">http://www.bilaterals.org/spip.php?article22926</guid>
		<dc:date>2013-03-27 08:39:52</dc:date>
		<dc:format>text/html</dc:format>
		<dc:language>en</dc:language>
		[<dc:creator></dc:creator>]


		<dc:subject>IPR</dc:subject>
		<dc:subject>medicines</dc:subject>
		<dc:subject>India</dc:subject>
		<dc:subject>EU</dc:subject>

		<description>&lt;p&gt;Drugmakers and healthcare activists are worried that the India-European Union Free Trade Agreement (FTA), which is in the works, may contain a provision that could imperil local industry and have urged the government to keep patent infringement issues out of FTAs.&lt;/p&gt;



		</description>





	</item>
<item xml:lang="en">
		<title> European Union-India FTA may hit generic medical industry</title>
		<link>http://www.bilaterals.org/spip.php?article22881</link>
		<guid isPermaLink="true">http://www.bilaterals.org/spip.php?article22881</guid>
		<dc:date>2013-03-21 06:56:41</dc:date>
		<dc:format>text/html</dc:format>
		<dc:language>en</dc:language>
		[<dc:creator></dc:creator>]


		<dc:subject>medicines</dc:subject>
		<dc:subject>EU</dc:subject>
		<dc:subject>India</dc:subject>
		<dc:subject>IPR</dc:subject>

		<description>&lt;p&gt;The free trade agreement that European Union is pushing India to sign could put an end to India's status as the pharmacy of the developing providing affordable medicines, especially HIV drugs to countries like Brazil, Thailand, South Africa, Zimbabwe and several others. The negotiations with EU are on at a feverish pace this week in Brussels even before the parliamentary standing committee looking into the free trade agreements (FTAs) has submitted its report.&lt;/p&gt;



		</description>





	</item>
<item xml:lang="en">
		<title>Trans-Pacific Partnership Agreement: an interview with Judit Rius, M&#233;decins Sans Fronti&#232;res</title>
		<link>http://www.bilaterals.org/spip.php?article22840</link>
		<guid isPermaLink="true">http://www.bilaterals.org/spip.php?article22840</guid>
		<dc:date>2013-03-12 15:40:52</dc:date>
		<dc:format>text/html</dc:format>
		<dc:language>en</dc:language>
		[<dc:creator></dc:creator>]


		<dc:subject>IPR</dc:subject>
		<dc:subject>medicines</dc:subject>
		<dc:subject>actions | resistance</dc:subject>
		<dc:subject>TPP</dc:subject>

		<description>&lt;p&gt;The TPP negotiators are making decisions that will affect at least 600 million people, and potentially hundreds of millions more, in complete secrecy, and this is unacceptable.&lt;/p&gt;



		</description>





	</item>
<item xml:lang="en">
		<title>EU-Thailand FTA negotiations: What fate for access to medicines?</title>
		<link>http://www.bilaterals.org/spip.php?article22806</link>
		<guid isPermaLink="true">http://www.bilaterals.org/spip.php?article22806</guid>
		<dc:date>2013-03-06 02:59:40</dc:date>
		<dc:format>text/html</dc:format>
		<dc:language>en</dc:language>
		[<dc:creator></dc:creator>]


		<dc:subject>Thailand</dc:subject>
		<dc:subject>EU</dc:subject>
		<dc:subject>medicines</dc:subject>
		<dc:subject>actions | resistance</dc:subject>

		<description>&lt;p&gt;Health Action International Europe, Oxfam and Action against AIDS Germany have serious concerns over the repercussions the EU-Thailand FTA will have on access to medicines in Thailand and the region.&lt;/p&gt;



		</description>





	</item>
<item xml:lang="en">
		<title>As clock ticks toward Trans-Pacific trade pact deadline, US must end stall tactics on access to medicines</title>
		<link>http://www.bilaterals.org/spip.php?article22805</link>
		<guid isPermaLink="true">http://www.bilaterals.org/spip.php?article22805</guid>
		<dc:date>2013-03-05 11:25:43</dc:date>
		<dc:format>text/html</dc:format>
		<dc:language>en</dc:language>
		[<dc:creator></dc:creator>]


		<dc:subject>US</dc:subject>
		<dc:subject>corporate interests </dc:subject>
		<dc:subject>medicines</dc:subject>
		<dc:subject>TPP</dc:subject>

		<description>&lt;p&gt;As closed-door talks for the Trans-Pacific Partnership Agreement resume in Singapore this week, international medical humanitarian organization M&#233;decins Sans Fronti&#232;res calls on the US government to end its stall tactics and revise its proposals for what otherwise promises to be the most harmful trade deal ever for access to medicines in developing countries.&lt;/p&gt;



		</description>





	</item>
<item xml:lang="en">
		<title>Thai-EU FTA raises alarm for people with AIDS</title>
		<link>http://www.bilaterals.org/spip.php?article22498</link>
		<guid isPermaLink="true">http://www.bilaterals.org/spip.php?article22498</guid>
		<dc:date>2012-12-30 07:11:56</dc:date>
		<dc:format>text/html</dc:format>
		<dc:language>en</dc:language>
		[<dc:creator></dc:creator>]


		<dc:subject>Thailand</dc:subject>
		<dc:subject>EU</dc:subject>
		<dc:subject>medicines</dc:subject>

		<description>&lt;p&gt;Days before leaders of the European Union arrived in Norway to collect this year's Nobel Peace prize, Thai public health activists sent a letter to the northern powerhouse, warning that the EU's 2012 accolades face a credibility test in this Southeast Asian country.&lt;/p&gt;



		</description>





	</item>
<item xml:lang="en">
		<title>Canada prepares for drug patent concessions to clinch free-trade deal with EU</title>
		<link>http://www.bilaterals.org/spip.php?article22302</link>
		<guid isPermaLink="true">http://www.bilaterals.org/spip.php?article22302</guid>
		<dc:date>2012-11-16 05:17:47</dc:date>
		<dc:format>text/html</dc:format>
		<dc:language>en</dc:language>
		[<dc:creator></dc:creator>]


		<dc:subject>EU</dc:subject>
		<dc:subject>Canada</dc:subject>
		<dc:subject>medicines</dc:subject>

		<description>&lt;p&gt;As free trade talks with the European Union reach the endgame, Ottawa is signalling it is prepared to give the Europeans at least part of what they asked for on drug patents &#8212; a move that could cost Canadians up to $900 million a year.&lt;/p&gt;



		</description>





	</item>
<item xml:lang="en">
		<title>EU free trade deal will hike drug prices in N.S. &#8212; minister</title>
		<link>http://www.bilaterals.org/spip.php?article22294</link>
		<guid isPermaLink="true">http://www.bilaterals.org/spip.php?article22294</guid>
		<dc:date>2012-11-15 14:42:49</dc:date>
		<dc:format>text/html</dc:format>
		<dc:language>en</dc:language>
		[<dc:creator></dc:creator>]


		<dc:subject>EU</dc:subject>
		<dc:subject>Canada</dc:subject>
		<dc:subject>IPR</dc:subject>
		<dc:subject>medicines</dc:subject>

		<description>&lt;p&gt;A concession on drug patents in a free trade deal with the European Union stands to cost Nova Scotians millions, Health and Wellness Minister David Wilson said Wednesday.&lt;/p&gt;



		</description>





	</item>
<item xml:lang="en">
		<title>EU trade policy cannot ignore the Geneva conventions: the European Parliament must reject the ACAA protocol with Israel</title>
		<link>http://www.bilaterals.org/spip.php?article22213</link>
		<guid isPermaLink="true">http://www.bilaterals.org/spip.php?article22213</guid>
		<dc:date>2012-10-22 06:59:00</dc:date>
		<dc:format>text/html</dc:format>
		<dc:language>en</dc:language>
		[<dc:creator></dc:creator>]


		<dc:subject>EU</dc:subject>
		<dc:subject>medicines</dc:subject>
		<dc:subject>Israel</dc:subject>
		<dc:subject>Palestine</dc:subject>
		<dc:subject>actions | resistance</dc:subject>

		<description>&lt;p&gt;Civil society statement calling fpr rejection of the Conformity Assessment and Acceptance of Industrial Products protocol attached to the European Union-Israel Association Agreement&lt;/p&gt;



		</description>





	</item>
<item xml:lang="en">
		<title>US pharma companies could be real beneficiaries of Canada-EU trade deal </title>
		<link>http://www.bilaterals.org/spip.php?article22097</link>
		<guid isPermaLink="true">http://www.bilaterals.org/spip.php?article22097</guid>
		<dc:date>2012-09-27 03:43:43</dc:date>
		<dc:format>text/html</dc:format>
		<dc:language>en</dc:language>
		[<dc:creator></dc:creator>]


		<dc:subject>US</dc:subject>
		<dc:subject>EU</dc:subject>
		<dc:subject>Canada</dc:subject>
		<dc:subject>IPR</dc:subject>
		<dc:subject>medicines</dc:subject>

		<description>&lt;p&gt;Although the EU is asking Canada to change its patent regime, it is not possible to do so just for the EU. The actual beneficiaries would be all of the world's brand-name companies. Of the world's top 12 health care companies by revenue only three or four are resident in the EU.&lt;/p&gt;



		</description>





	</item>
<item xml:lang="en">
		<title>HIV patients urge caution on EU FTA talks</title>
		<link>http://www.bilaterals.org/spip.php?article22078</link>
		<guid isPermaLink="true">http://www.bilaterals.org/spip.php?article22078</guid>
		<dc:date>2012-09-22 22:19:22</dc:date>
		<dc:format>text/html</dc:format>
		<dc:language>en</dc:language>
		[<dc:creator></dc:creator>]


		<dc:subject>Thailand</dc:subject>
		<dc:subject>EU</dc:subject>
		<dc:subject>ASEAN</dc:subject>
		<dc:subject>IPR</dc:subject>
		<dc:subject>medicines</dc:subject>

		<description>&lt;p&gt;People afflicted with the Aids virus have called on the government to proceed carefully on free-trade negotiations with the European Union, as the latter's demands for copyright protection could make it difficult for patients to access cheap medicines.&lt;/p&gt;



		</description>





	</item>



</channel>

</rss>
